# Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis

> **NCT04149405** · PHASE4 · COMPLETED · sponsor: **Ondokuz Mayıs University** · enrollment: 43 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal
- Periodontitis

## Interventions

- **PROCEDURE:** Phase 1 periodontal therapy
- **DRUG:** Bisphosphonate therapy

## Key facts

- **NCT ID:** NCT04149405
- **Lead sponsor:** Ondokuz Mayıs University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2017-12-06
- **Final completion:** 2018-12-28
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04149405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04149405, "Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04149405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*